Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells


The Company
Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics that target both cancer stem cells (CSCs) and tumor bulk.
Clinical Trials
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen to identify novel compounds that target and kill CSCs.


News
&
Events
5/14/2015
Stemline Therapeutics to Present at the UBS Global Healthcare Conference
5/11/2015
Stemline Therapeutics Reports First Quarter 2015 Financial Results
3/13/2015
Stemline Therapeutics Reports Fourth Quarter 2014 Financial Results
Copyright 2015 - Stemline Therapeutics, Inc. All rights reserved
Stemline